利尔化学股份有限公司 2018 年第一季度报告正文 证券代码：002258 证券简称：利尔化学 公告编号：2018-024 利尔化学股份有限公司 2018 年第一季度报告正文 1 利尔化学股份有限公司 2018 年第一季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)符眉冷声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2018 年第一季度报告正文 √ 适用 □ 不适用 单位：元 | 项目 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | | 非流动资产处置损益（包括已计提资产减值准备的冲销部分） | 454,785.26 | | | 计入当期损益的政府补助（与企业业务密切相关，按照国家统一标 | 3,822,561.50 | | | 准定额或定量享受的政府补助除外） | | | | 除同公司正常经 ...

利尔化学股份有限公司 2017 年年度报告全文 利尔化学股份有限公司 2017 年年度报告 2018 年 01 月 1 利尔化学股份有限公司 2017 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)陈俊声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异，请投资者注意投资风险。 4 利尔化学股份有限公司 2017 年年度报告全文 第二节 公司简介和主要财务指标 一、公司信息 公司存在市场竞争风险、原材料价格波动风险、环保风险、安全生产风险、 大规模建设投入导致利润下滑的风险，敬请广大投资者注意投资风险。详细内 容见本报告"第四节 九、（五）可能面对的风险因素"。 公司计划不派发现金红利，不 ...

利尔化学股份有限公司 2017 年第三季度报告正文 证券代码：002258 证券简称：利尔化学 公告编号：2017-042 利尔化学股份有限公司 2017 年第三季度报告正文 1 利尔化学股份有限公司 2017 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)陈俊声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2017 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 对公司根据《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》定义界定的非经常性损益项目，以及把《公 开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常性损益项目界定为经常性损益的项目，应 说明原因 □ 适用 √ 不适用 公司报告期不存在将根据《公开发行证券的公司信息披露解释性公告第 1 号——非 ...

利尔化学股份有限公司 2017 年半年度报告全文 利尔化学股份有限公司 2017 年半年度报告 2017 年 08 月 1 利尔化学股份有限公司 2017 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)陈俊声明：保证本半年度报告中财务报告的真实、准确、完整。 除下列董事外，其他董事亲自出席了审议本次半年报的董事会会议 | 未亲自出席董事姓名 | 未亲自出席董事职务 | 未亲自出席会议原因 | 被委托人姓名 | | --- | --- | --- | --- | | 潘力佳 | 董事 | 有事请假 | 徐士辉 | 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，请投资者注意投资风险。 公司存在市场竞争风险、原材料价格波动风险、环保风险、安全生产风险、 大规模建设投入导致利润下滑的风险，敬请广大投资者注意投资风险。详细内 容见本报告"第四节 十、公司面临的风险和 ...

利尔化学股份有限公司 2017 年第一季度报告正文 证券代码：002258 证券简称：利尔化学 公告编号：2017-018 利尔化学股份有限公司 2017 年第一季度报告正文 1 利尔化学股份有限公司 2017 年第一季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)陈俊声明：保证季度报告中财务报表的真实、准确、完整。 非经常性损益项目和金额 √ 适用 □ 不适用 2 利尔化学股份有限公司 2017 年第一季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 525,513,687.60 | 470,037,658.25 | ...

利尔化学股份有限公司 2016 年年度报告全文 利尔化学股份有限公司 2017 年 02 月 1 利尔化学股份有限公司 2016 年年度报告全文 第一节 重要提示、目录和释义 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)陈俊声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异，请投资者注意投资风险。 公司存在市场竞争风险、原材料价格波动风险、环保风险、安全生产风险、 大规模建设投入导致利润下滑的风险，敬请广大投资者注意投资风险。详细内 容见本报告"第四节 九、（五）可能面对的风险因素"。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2016 年年度报告 2 | 目录 | | --- | | 第一节 | 重要提示、目录和 ...

Financial Performance - Operating revenue for the period was CNY 486,442,698.25, representing a 68.76% increase year-on-year[8] - Net profit attributable to shareholders was CNY 36,962,815.64, up 63.69% compared to the same period last year[8] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 38,586,459.39, a 93.00% increase year-on-year[8] - Basic earnings per share increased by 75.00% to CNY 0.07[8] - Investment income increased by 116.9% compared to the same period last year, mainly due to improved performance of the joint venture Jiangyou Qiming Chlor-Alkali Company[15] Assets and Shareholder Information - Total assets increased by 13.72% to CNY 2,907,482,892.49 compared to the end of the previous year[8] - Net assets attributable to shareholders increased by 50.98% to CNY 1,961,442,068.69 compared to the end of the previous year[8] - The number of ordinary shareholders at the end of the reporting period was 24,374[11] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 27.36% of the shares[11] Cash Flow and Financial Management - The company reported a net cash flow from operating activities of CNY 61,364,130.37, down 45.99% year-to-date[8] - Financial expenses decreased by 49.14% compared to the same period last year, primarily due to increased exchange gains and reduced interest expenses from loan repayments[15] - Cash paid for dividends, profits, or interest repayment increased by 315.49% compared to the same period last year, primarily due to dividend payments made during the period[16] Changes in Assets - Accounts receivable increased by 34.33% compared to the beginning of the period, mainly due to increased sales revenue and extended credit terms[15] - Construction in progress increased by 34.54% compared to the beginning of the period, primarily due to increased investment in the company's glyphosate raw material project and environmental engineering upgrades[15] - Long-term prepaid expenses increased by 45.19% compared to the beginning of the period, mainly due to increased land rent and reclamation fees[15] - Other non-current assets increased by 197.07% compared to the beginning of the period, mainly due to increased prepayments for land and equipment purchases[15] Management and Operational Expenses - The company's management expenses increased by 34.89% compared to the same period last year, mainly due to increased salaries, depreciation, and travel expenses as the business expanded[15] Future Projections - The company's net profit attributable to shareholders for 2016 is expected to increase by 10.00% to 40.00%, with a projected range of RMB 152.30 million to RMB 193.84 million[21] Corporate Actions - The company completed a rights issue during the reporting period, which was approved by the shareholders' meeting and the China Securities Regulatory Commission[17] Return on Equity - The weighted average return on equity was 2.80%, a decrease of 56.42% compared to the same period last year[8]

Financial Performance - The company achieved operating revenue of CNY 918.19 million, a year-on-year increase of 13.54%[20] - Net profit attributable to shareholders reached CNY 97.97 million, up 10.64% compared to the same period last year[20] - The net profit after deducting non-recurring gains and losses was CNY 97.92 million, reflecting a growth of 14.23% year-on-year[20] - The company's revenue for the reporting period was approximately ¥918.19 million, representing a year-on-year increase of 13.54% compared to ¥808.69 million in the same period last year[31] - Operating costs increased to approximately ¥681.37 million, up 11.43% from ¥611.45 million year-on-year[31] - The net profit for the period was CNY 103.22 million, representing a 15.8% increase from CNY 89.22 million in the previous year[118] - The net profit attributable to the parent company was CNY 97.97 million, compared to CNY 88.55 million in the same period last year, reflecting a growth of 10.4%[118] Cash Flow and Liquidity - The net cash flow from operating activities decreased significantly by 90.76% to CNY 8.50 million[20] - The net cash flow from operating activities significantly dropped by 90.76% to approximately ¥8.50 million, primarily due to an increase in accounts receivable and rising expenses[31] - The net cash flow from financing activities surged by 571.10% to approximately ¥276.76 million, mainly due to funds received from a rights issue[31] - The company reported a net increase in cash and cash equivalents of approximately ¥104.35 million, a significant turnaround from a decrease of ¥23.01 million in the previous year[31] - The operating cash flow for the current period is CNY 8,499,974.77, a significant decrease of 90.8% compared to CNY 92,038,791.17 in the previous period[124] - The company reported a cash and cash equivalents balance of CNY 263,096,218.67 at the end of the period, an increase from CNY 68,782,592.81 at the end of the previous period[125] Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 2.90 billion, an increase of 13.56% from the previous year[20] - The total assets of Lier Chemical Co., Ltd. increased to CNY 2,903,332,581.86, up from CNY 2,556,676,265.72 at the beginning of the period, representing a growth of approximately 13.5%[110] - Current assets rose to CNY 1,203,326,688.48, compared to CNY 990,980,745.23 at the start of the period, indicating an increase of about 21.4%[111] - Total liabilities decreased to CNY 726,627,882.35 from CNY 1,005,218,123.82, representing a reduction of about 27.7%[112] - The company's equity increased significantly, with total equity reaching CNY 2,176,704,699.51, up from CNY 1,551,458,141.90, indicating a growth of approximately 40.3%[112] Market Expansion and Strategy - The company is actively expanding both domestic and international markets, enhancing sales channels and adjusting marketing strategies[28] - The company has made significant progress in expanding its international market presence and enhancing its product development capabilities[32] - The company plans to continue strengthening internal management and cost reduction to ensure stable production and product supply[28] - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[118] Shareholder and Equity Information - The company completed a cash dividend distribution of CNY 2 per share and a bonus share distribution of 5 shares for every 10 shares held[56] - The adjusted basic earnings per share for the reporting period was 0.28 CNY, with the net asset value per share for ordinary shareholders at 2.66 CNY[92] - The total number of ordinary shareholders at the end of the reporting period was 24,423[96] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., held 27.36% of shares, totaling 143,484,136 shares, with 7,501,272 shares frozen[96] - The company completed a share issuance, adding 59,742,482 shares, resulting in a total share capital of 262,186,515 shares[91] Governance and Compliance - The company maintained compliance with corporate governance regulations and improved its governance structure[67] - The company has not encountered any issues or other situations in the use and disclosure of raised funds during the reporting period[48] - The company did not engage in any major litigation or arbitration matters during the reporting period[63] - The company has not faced any penalties or rectification situations during the reporting period[85] Financial Reporting and Accounting Policies - The financial report for the first half of 2016 was not audited, which may impact the reliability of the financial data presented[108] - The company adheres to the accrual basis of accounting, ensuring that revenues and expenses are recognized when they are incurred, regardless of cash flow[149] - The financial statements comply with the requirements of the accounting standards and reflect the company's financial position as of June 30, 2016[155] Investment and Capital Management - The total amount raised from the rights issue was approximately ¥575.61 million, which will be used to supplement working capital[46] - The company raised a total of CNY 57,560.8 million for supplementary working capital, achieving 100% of the planned investment[48] - The company has not engaged in any major contracts or transactions during the reporting period[80][81] Research and Development - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not mentioned in the provided data[131] - The company is progressing with the construction of a technical transformation project for an annual output of 5,000 tons of glyphosate raw materials[28]

Financial Performance - The company's revenue for Q1 2016 was ¥470,037,658.25, representing a 46.20% increase compared to ¥321,501,525.44 in the same period last year[8] - Net profit attributable to shareholders was ¥39,569,663.69, up 34.04% from ¥29,519,917.30 year-on-year[8] - The net profit excluding non-recurring gains and losses was ¥37,730,414.19, reflecting a 31.64% increase from ¥28,661,942.77 in the previous year[8] - The basic earnings per share increased by 16.67% to ¥0.07 from ¥0.06 in the same period last year[8] - Operating revenue increased by 46.20% year-on-year, attributed to favorable market conditions and increased sales[16] - Operating costs rose by 46.12% year-on-year, corresponding to the increase in revenue[16] - Sales expenses increased by 58.43% year-on-year, mainly due to transportation costs associated with increased product sales[16] - The estimated net profit attributable to shareholders for the first half of 2016 is expected to range from 7,526.96 to 10,183.54 thousand yuan, reflecting a change of -15.00% to 15.00% compared to the same period in 2015[19] Assets and Shareholder Equity - The company's total assets increased by 13.04% to ¥2,890,013,423.01 from ¥2,556,676,265.72 at the end of the previous year[8] - The net assets attributable to shareholders rose by 43.47% to ¥1,863,906,075.78 compared to ¥1,299,166,188.18 at the end of the last year[8] - Cash and cash equivalents increased by 119.69% compared to the beginning of the period, mainly due to funds raised from the rights issue[16] - Accounts receivable increased by 37.93% compared to the beginning of the period, primarily due to increased sales revenue[16] Cash Flow - The company reported a negative net cash flow from operating activities of ¥41,471,408.96, a decline of 196.34% compared to a positive cash flow of ¥43,045,469.25 in the previous year[8] - Net cash flow from operating activities decreased by 196.34% year-on-year, primarily due to an increase in accounts receivable and the rise in acceptance bills during cash collection[16] - The net cash received from the disposal of fixed assets increased by 901.2% year-on-year, mainly due to the disposal of fixed assets by a subsidiary[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,967[11] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., held 27.36% of the shares, amounting to 71,742,068 shares[11] Corporate Actions and Future Plans - The company completed a share placement to meet funding needs, which was approved by the China Securities Regulatory Commission in December 2015[15] - The company plans to continue focusing on the development of new products and technologies to enhance market competitiveness[19] - The company has no non-operating fund occupation by controlling shareholders or related parties during the reporting period[21]

Financial Performance - The company's operating revenue for 2015 was CNY 1,489,071,485.32, representing a 13.03% increase compared to CNY 1,317,389,551.39 in 2014[18]. - The net profit attributable to shareholders for 2015 was CNY 138,453,579.30, a significant increase of 49.82% from CNY 92,412,057.32 in 2014[18]. - The net profit after deducting non-recurring gains and losses was CNY 126,718,112.81, up 35.63% from CNY 93,429,766.30 in the previous year[18]. - The basic earnings per share for 2015 was CNY 0.68, an increase of 47.83% compared to CNY 0.46 in 2014[18]. - The total assets at the end of 2015 reached CNY 2,556,676,265.72, reflecting a 25.20% increase from CNY 2,042,131,044.63 at the end of 2014[18]. - The net assets attributable to shareholders increased by 12.09% to CNY 1,299,166,188.18 from CNY 1,159,056,228.37 in 2014[18]. - The net cash flow from operating activities for 2015 was CNY 156,796,906.49, an increase of 11.73% from CNY 140,335,346.77 in 2014[18]. - The weighted average return on equity for 2015 was 11.27%, up from 8.26% in 2014, indicating improved profitability[18]. Revenue Breakdown - The pesticide industry accounted for 98.62% of total revenue, with pesticide raw materials generating ¥884.36 million, a 13.26% increase from ¥780.84 million in 2014[39]. - Domestic sales increased by 25.47% to ¥908.49 million, while international sales decreased by 4.99% to ¥559.99 million[39]. - The company's total operating revenue for 2015 was approximately ¥1.49 billion, representing a year-on-year increase of 13.03% compared to ¥1.32 billion in 2014[39]. Investments and Assets - The fixed asset net value increased by 34.85% due to the completion of the grass ammonium production line investment[29]. - The intangible asset net value rose by 31.34% following the acquisition of new land use rights[29]. - The company's total assets composition showed a significant increase in cash and cash equivalents, rising from 4.58% to 6.43% of total assets[53]. - Fixed assets increased to ¥1,173,592,871.48, accounting for 45.90% of total assets, up from 42.62%[54]. Market and Production - The company completed the technical transformation and capacity expansion of its main production line, significantly enhancing supply assurance capabilities[34]. - The company has developed over 30 active ingredients and 90 formulations, focusing on high-efficiency, low-toxicity, and low-residue pesticides[27]. - The company is recognized as the largest producer of glyphosate in China and has established a leading position in the chlorinated pyridine pesticide market[28]. - The company's pesticide production volume reached 26,720,753.47 kg, a 25.34% increase from 21,318,432.75 kg in 2014[42]. Cash Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 2 per 10 shares and issue 5 bonus shares for every 10 shares held[4]. - In 2015, the company distributed cash dividends of 52,437,303 RMB, representing 37.87% of the net profit attributable to ordinary shareholders[81]. - The cash dividend for 2015 was set at 2 RMB per 10 shares, along with a stock dividend of 5 shares per 10 shares[82]. - The total distributable profit for 2015 was 475,092,042.01 RMB, with cash dividends constituting 28.57% of the total profit distribution[82]. Environmental and Social Responsibility - The company has invested over 200 million yuan in environmental protection measures, ensuring compliance with national standards for waste emissions[66]. - The company has established an "Lier Chemical Love Fund" to assist employees facing sudden hardships, having helped over 44 employees with a total amount of nearly RMB 170,000 since 2012[120]. - The company has implemented various environmental management systems and emergency plans to ensure compliance with environmental laws and regulations[121]. - The company has constructed a 60,000 Nm³/h waste gas thermal oxidation device to treat VOCs, with an additional unit currently under construction[124]. Governance and Management - The company has a diverse board with independent directors holding significant academic and industry experience, contributing to strategic decision-making[148]. - The management team is committed to maintaining strong governance and oversight, ensuring alignment with shareholder interests[146]. - The company has established a fair and transparent performance evaluation and incentive mechanism for its board members and management[166]. - The independent directors actively participated in corporate governance and decision-making, providing valuable professional opinions on system improvement and operational development[173]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[197]. - The company aims to enhance its international market presence and strengthen foreign registrations while developing domestic brand formulations[64]. - The company plans to raise up to RMB 600 million through a rights issue, with the issuance ratio set at a maximum of 3 shares for every 10 shares held[111].